What Are Clinical Trials for Mesothelioma?

What Clinical Trials Are and Why They Matter

Clinical trials are research studies that evaluate new treatments, drugs, or treatment combinations in human participants. For mesothelioma patients, clinical trials are particularly important because this cancer is rare and aggressive, and standard treatments have limitations. Every current standard treatment for mesothelioma — including the pemetrexed/cisplatin chemotherapy regimen and the Opdivo plus Yervoy immunotherapy combination — was proven effective through clinical trials before becoming widely available.

According to the National Cancer Institute, clinical trials are the final step in a long research process and are essential for determining whether new treatments are safe and effective. For mesothelioma patients, they may provide access to therapies that are not yet available through any other means.

Understanding the Phases

Clinical trials proceed through distinct phases, each with specific goals and participant requirements.

Phase I trials are the earliest stage of testing in humans. They involve a small group of participants (typically 15 to 30) and focus primarily on determining the safe dosage of a new treatment and identifying side effects. Phase I trials are often available to patients who have exhausted standard treatment options.

Phase II trials expand the study to a larger group (often 30 to 100+ participants) and evaluate whether the treatment is effective against the specific cancer. Researchers also continue to monitor safety. Many promising mesothelioma treatments are currently in Phase II testing.

Phase III trials compare the new treatment directly against the current standard of care in a large group of patients (hundreds to thousands). These randomized trials provide the strongest evidence of effectiveness. The CheckMate 743 trial that led to FDA approval of Opdivo plus Yervoy was a Phase III trial.

Phase IV trials occur after a treatment has been approved by the FDA. They monitor long-term effectiveness and side effects in a broader patient population and may explore new uses for the approved drug.

Current Areas of Research

Mesothelioma research is active across several promising areas. Current clinical trials are investigating treatments that could significantly improve outcomes for patients.

Immunotherapy combinations. Building on the success of Opdivo plus Yervoy, researchers are testing new combinations of checkpoint inhibitors, combining immunotherapy with chemotherapy, and exploring entirely new classes of immunotherapy drugs. Pembrolizumab (Keytruda), another checkpoint inhibitor, is being studied in multiple mesothelioma trials.

Targeted therapy. These drugs target specific molecular features of mesothelioma cells. Researchers are investigating drugs that target the BAP1 gene mutation (found in many mesothelioma tumors), angiogenesis inhibitors that cut off the tumor's blood supply, and drugs targeting specific signaling pathways that drive mesothelioma growth.

Gene therapy. This approach involves modifying the genetic material of cancer cells or immune cells to fight the disease. Some gene therapy trials use modified viruses to deliver tumor-killing genes directly to mesothelioma cells.

Photodynamic therapy (PDT). PDT uses light-activated drugs that are absorbed by cancer cells. When activated by a specific wavelength of light during surgery, these drugs destroy cancer cells while sparing healthy tissue. PDT is being studied as an addition to surgery for pleural mesothelioma.

How to Find and Enroll in a Trial

Finding an appropriate clinical trial involves several steps, and your oncologist is an important partner in this process.

Search ClinicalTrials.gov. This database, maintained by the National Institutes of Health, lists all registered clinical trials in the United States and many international studies. You can search by condition (mesothelioma), treatment type, location, and trial phase.

Contact the NCI Cancer Information Service. The National Cancer Institute provides free assistance in identifying clinical trials appropriate for your specific diagnosis and situation.

Ask your oncologist. Your treating physician can evaluate whether you meet the eligibility criteria for specific trials and can refer you to participating centers. Oncologists at major cancer centers are often directly involved in mesothelioma research.

Contact mesothelioma treatment centers. Specialized centers that treat high volumes of mesothelioma patients typically have multiple active clinical trials and dedicated research coordinators who can guide you through the enrollment process.

Eligibility, Costs, and What to Expect

Each clinical trial has specific eligibility criteria that determine who can participate. Common requirements include a confirmed mesothelioma diagnosis (specific type and stage may be required), adequate organ function as measured by blood tests, the ability to perform basic daily activities (measured by performance status), and in some cases, prior treatment with standard therapies.

Cost. The experimental treatment provided in a clinical trial is typically free to participants. Routine care costs (doctor visits, standard tests) are usually covered by insurance. Some trials also cover travel expenses. The American Cancer Society notes that federal law requires most insurance plans to cover routine patient care costs during a clinical trial.

Benefits and risks. Benefits include access to new treatments before they are widely available, close monitoring by a research team, and contributing to research that may help future patients. Risks include potential unknown side effects, the possibility that the new treatment may not be more effective than standard care, and the time commitment involved in additional visits and tests.

Questions to Ask Your Doctor

If you are considering a clinical trial, these questions can help you make an informed decision: What trials am I eligible for based on my diagnosis and treatment history? What is the goal of this trial and what phase is it in? What are the known risks and potential benefits? How will the trial treatment compare to my current treatment options? What costs will be covered, and what will I be responsible for? How often will I need to visit the trial site, and where is it located?

Your care team can help you weigh the potential benefits against the practical considerations of participating in a trial. For many mesothelioma patients, clinical trials represent an important avenue for accessing the newest and most promising treatments available.